Huber, M.B. ; Schneider, N. ; Kirsch, F. ; Schwarzkopf, L. ; Schramm, A.* ; Leidl, R.
Long-term weight gain in obese COPD patients participating in a disease management program: A risk factor for reduced health-related quality of life.
Respir. Res. 22:226 (2021)
Kirsch, F. ; Schramm, A.* ; Kurz, C.F. ; Schwarzkopf, L. ; Lutter, J. ; Huber, M.B. ; Leidl, R.
Effect of BMI on health care expenditures stratified by COPD GOLD severity grades: Results from the LQ-DMP study.
Respir. Med. 175:106194 (2020)
Milivojevic, M.* ; Che, X.* ; Bateman, L.* ; Cheng, A.* ; Garcia, B.A.* ; Hornig, M.* ; Huber, M.B. ; Klimas, N.G.* ; Lee, B.* ; Lee, H.* ; Levine, S.* ; Montoya, J.G.* ; Peterson, D.L.* ; Komaroff, A.L.* ; Lipkin, W.I.*
Plasma proteomic profiling suggests an association between antigen driven clonal B cell expansion and ME/CFS.
PLoS ONE 15:e0236148 (2020)
Huber, M.B. ; Kurz, C.F. ; Kirsch, F. ; Schwarzkopf, L. ; Schramm, A.* ; Leidl, R.
The relationship between body mass index and health-related quality of life in COPD: Real-world evidence based on claims and survey data.
Respir. Res. 21:291 (2020)
Szentes, B.L. ; Schwarzkopf, L. ; Kirsch, F. ; Huber, M.B. ; Schramm, A.* ; Leidl, R.
Different methods to classify COPD patients into the ABCD severity groups - Preliminary results of the LQ-DMP project.
Eur. Respir. J. 54 (2019)
Kirsch, F. ; Schramm, A.* ; Schwarzkopf, L. ; Lutter, J. ; Szentes, B.L. ; Huber, M.B. ; Leidl, R.
Direct and indirect costs of COPD progression and its comorbidities in a structured disease management program: Results from the LQ-DMP study.
Respir. Res. 20:215 (2019)
Kirsch, F. ; Schramm, A.* ; Schwarzkopf, L. ; Szentes, B.L. ; Lutter, J. ; Huber, M.B. ; Leidl, R.
Influence of COPD severity and its comorbidities on direct and indirect costs: Results from the LQ-DMP study.
Value Health 22, S876-S876 (2019)
Huber, M.B. ; Kurz, C.F. ; Leidl, R.
Predicting patient-reported outcomes following hip and knee replacement surgery using supervised machine learning.
BMC Med. Inform. Decis. Mak. 19:3 (2019)
Huber, M.B. ; Präger, M. ; Coyle, K.* ; Coyle, D.* ; Lester-George, A.* ; Trapero-Bertran, M.* ; Nemeth, B.* ; Cheung, K.L.* ; Stark, R.G. ; Vogl, M. ; Pokhrel, S.* ; Leidl, R.
Cost-effectiveness of increasing the reach of smoking cessation interventions in Germany: Results from the EQUIPTMOD.
Addiction 113, 1, 52-64 (2018)
Németh, B.* ; Józwiak-Hagymásy, J.* ; Kovács, G.* ; Kovács, A.L.* ; Demjén, T.* ; Huber, M.B. ; Cheung, K.L.* ; Coyle, K.* ; Lester-George, A.* ; Pokhrel, S.* ; Vokó, Z.*
Cost-effectiveness of possible future smoking cessation strategies in Hungary: Results from the EQUIPTMOD.
Addiction 113, 1, 76-86 (2018)
Huber, M.B. ; Vogelmann, M.* ; Leidl, R.*
Valuing health-related quality of life: Systematic variation in health perception.
Health Qual. Life Outcomes 16:156 (2018)
Huber, M.B. ; Felix, J.F. ; Vogelmann, M.* ; Leidl, R.
Health-related quality of life of the general German population in 2015: Results from the EQ-5D-5L.
Int. J. Environ. Res. Public Health 14:426 (2017)
Azencott, C.* ; Aittokallio, T.* ; Roy, S.* ; Norman, T.* ; Friend, S.* ; Stolovitzky, G.* ; Goldenberg, A.* ; DREAM Idea Challenge Consortium (Huber, M.B.) ; DREAM Idea Challenge Consortium (Kurz, C.F.)
The inconvenience of data of convenience: Computational research beyond post-mortem analyses.
Nat. Methods 14, 937-938 (2017)
Huber, M.B. ; Reitmeir, P. ; Vogelmann, M.* ; Leidl, R.
EQ-5D-5L in the general German population: Comparison and evaluation of three yearly cross-section surveys.
Int. J. Environ. Res. Public Health 13:343 (2016)
Huber, M.B. ; Wacker, M. ; Vogelmeier, C.F.* ; Leidl, R.
Comorbid influences on generic health-related quality of life in COPD: A systematic review.
PLoS ONE 10:e0132670 (2015)
Huber, M.B. ; Wacker, M. ; Vogelmeier, C.F.* ; Leidl, R.
Excess costs of comorbidities in chronic obstructive pulmonary disease: A systematic review.
PLoS ONE 10:e0123292 (2015)